These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 355562)

  • 1. Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema.
    Cheung HS; Nicoloff JT; Kamiel MB; Spolter L; Nimni ME
    J Invest Dermatol; 1978 Jul; 71(1):12-7. PubMed ID: 355562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid synthesis in fibroblasts of pretibial myxedema.
    Hanke CW; Bergfeld WF; Guirguis MN; Lewis LJ
    Cleve Clin Q; 1983; 50(2):129-32. PubMed ID: 6640929
    [No Abstract]   [Full Text] [Related]  

  • 3. Pretibial myxoedema: stimulation of mucopolysaccharide production of fibroblasts by serum.
    Jolliffe DS; Gaylarde PM; Brock AP; Sarkany I
    Br J Dermatol; 1979 Nov; 101(5):557-60. PubMed ID: 160243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G of patients with circumscribed pretibial myxedema of Graves' disease stimulates proteoglycan synthesis in human skin fibroblasts in culture.
    Shishiba Y; Imai Y; Odajima R; Ozawa Y; Shimizu T
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):44-51. PubMed ID: 1519422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.
    Chang TC; Wu SL; Hsiao YL; Kuo ST; Chien LF; Kuo YF; Change CC; Chang TJ
    Clin Immunol Immunopathol; 1994 Apr; 71(1):113-20. PubMed ID: 8137554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local immune microenvironment of skin may play an important role in the development of pretibial myxedema.
    Chen X; Dong J; Zhang L; Zhao X; Shi R; Pan M; Zheng J
    Exp Dermatol; 2021 Dec; 30(12):1820-1824. PubMed ID: 34047397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin fibroblast activity in pretibial myxoedema and the effect of octreotide (Sandostatin) in vitro.
    Priestley GC; Aldridge RD; Sime PJ; Wilson D
    Br J Dermatol; 1994 Jul; 131(1):52-6. PubMed ID: 8043422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of pretibial myxedema associated with Graves' disease: an immunohistochemical study of serum-derived hyaluronan-associated protein.
    Shishido M; Kuroda K; Tsukifuji R; Fujita M; Shinkai H
    J Dermatol; 1995 Dec; 22(12):948-52. PubMed ID: 8648004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory pretibial myxoedema with response to intralesional insulin-like growth factor 1 antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts.
    Shinohara M; Hamasaki Y; Katayama I
    Br J Dermatol; 2000 Nov; 143(5):1083-6. PubMed ID: 11069527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy.
    Imai Y; Odajima R; Shimizu T; Shishiba Y
    Endocrinol Jpn; 1990 Oct; 37(5):749-52. PubMed ID: 1982261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euthyroid pretibial myxedema.
    Chen JJ; Ladenson PW
    Am J Med; 1987 Feb; 82(2):318-20. PubMed ID: 3812528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural and immunological findings in Graves' disease with pretibial myxedema.
    Konrad K; Brenner W; Pehamberger H
    J Cutan Pathol; 1980 Apr; 7(2):99-108. PubMed ID: 6989863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease.
    Heufelder AE; Wenzel BE; Gorman CA; Bahn RS
    J Clin Endocrinol Metab; 1991 Oct; 73(4):739-45. PubMed ID: 1890149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical characterization of high buoyant density proteoglycan accumulated in the affected skin of pretibial myxedema of Graves' disease.
    Shishiba Y; Tanaka T; Ozawa Y; Shimizu T; Kadowaki N
    Endocrinol Jpn; 1986 Jun; 33(3):395-403. PubMed ID: 3093207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy.
    Daumerie C; Ludgate M; Costagliola S; Many MC
    Eur J Endocrinol; 2002 Jan; 146(1):35-8. PubMed ID: 11751064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needles.
    Vannucchi G; Campi I; Covelli D; Forzenigo L; Beck-Peccoz P; Salvi M
    Thyroid; 2013 May; 23(5):626-32. PubMed ID: 23397966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema.
    Chang CC; Chang TC; Kao SC; Kuo YF; Chien LF
    Acta Endocrinol (Copenh); 1993 Oct; 129(4):322-7. PubMed ID: 8237250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretibial Myxedema Masquerading as a Venous Leg Ulcer.
    Herskovitz I; Hughes O; MacQuhae F; Kirsner RS
    Wounds; 2017 Mar; 29(3):77-79. PubMed ID: 28355140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.